ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,151 | – | 103 | +1960.0% | 0.00% | – |
Q1 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 5 | -99.8% | 0.00% | -100.0% |
Q1 2017 | $95,000 | -57.4% | 3,083 | -53.7% | 0.07% | -58.2% |
Q4 2016 | $223,000 | +112.4% | 6,663 | +86.1% | 0.16% | +64.6% |
Q1 2016 | $105,000 | -11.0% | 3,580 | 0.0% | 0.10% | -10.3% |
Q4 2015 | $118,000 | -33.3% | 3,580 | -26.8% | 0.11% | -32.7% |
Q3 2015 | $177,000 | -19.5% | 4,888 | 0.0% | 0.16% | -10.2% |
Q2 2015 | $220,000 | +46.7% | 4,888 | 0.0% | 0.18% | +47.5% |
Q1 2015 | $150,000 | – | 4,888 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |